Drug intelligence / Profile preview

mecobalamin

Development stage
Phase 4
Lead developer
Eisai
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Injection, Intramuscular, Intravenous, Sublingual
01

Overview

Mecobalamin is a synthetic and active form of vitamin B12 that can cross the blood-brain barrier without biotransformation. It is used to treat or prevent vitamin B12 deficiency and its complications[1][2]. As an activated coenzyme form of cobalamin (vitamin B12), mecobalamin participates directly in homocysteine metabolism as a coenzyme for methionine synthase. This enzyme is required for the conversion of homocysteine to methionine in the methylation cycle—an essential process for DNA and protein methylation[5]. Clinically it has been used to treat nutritional diseases related to B12 deficiency as well as neurological disorders such as diabetic neuropathy and peripheral neuropathies[2][4][5]. Evidence suggests it may promote nerve regeneration and provide neuroprotection by antagonizing glutamate-induced neurotoxicity. It has also shown potential analgesic effects in conditions like diabetic neuropathy and neuralgia by improving nerve conduction velocity and reducing pain behaviors[5].

Brand names
Mecobalamin DKMecobalamin JGMecobalamin NPMecobalamin TowaMecobalamin TsuruharaMecobalamin YDMecobamideMecobestMecobinMeconervMeconeuroMecozen Plus ForteMecozen-GB
Other names
methylcobalaminvitamin B12 (active form)cobalamin
02

Targets

MTR (Methionine synthase)

Beyond the preview

Go deeper on mecobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mecobalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call